Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04138381
Title Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST)
Acronym SeliGIST
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Virgen del Rocio Sevilla Andalucia 41013 Spain Details
H Vall d'Hebrón Barcelona Catalonia 08035 Spain Details
Hospital Universitario de Canarias Tenerife Islas Canarias 238320 Spain Details
Hospital Miguel Servet Zaragoza Zaragoza, Aragón 50009 Spain Details
Hospital La Paz Madrid 28046 Spain Details
Hospital Virgen de la Arrixaca Murcia 30120 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field